|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-8-5
|
|
pubmed:abstractText |
Resistance to antiretroviral combination therapy is associated with increased mortality. Understanding the relative risks of emerging resistance to first-line therapy is of importance for both resource-rich and resource-poor settings.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
712-22
|
|
pubmed:meshHeading |
pubmed-meshheading:18662137-Adult,
pubmed-meshheading:18662137-Anti-HIV Agents,
pubmed-meshheading:18662137-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18662137-Clinical Trials as Topic,
pubmed-meshheading:18662137-Drug Resistance, Viral,
pubmed-meshheading:18662137-HIV Infections,
pubmed-meshheading:18662137-HIV Reverse Transcriptase,
pubmed-meshheading:18662137-HIV-1,
pubmed-meshheading:18662137-Humans,
pubmed-meshheading:18662137-Incidence,
pubmed-meshheading:18662137-Mutation, Missense,
pubmed-meshheading:18662137-Treatment Failure,
pubmed-meshheading:18662137-Treatment Outcome,
pubmed-meshheading:18662137-Young Adult
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials.
|
|
pubmed:affiliation |
Division of Infection and Immunity, University College London, London, United Kingdom. Rgupta2@nhs.net
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
